Wave Life Sciences Toekomstige groei
Future criteriumcontroles 2/6
Wave Life Sciences zal naar verwachting groeien in winst en omzet met respectievelijk 38.1% en 42.4% per jaar. De winst per aandeel zal naar verwachting groeien met 42.8% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting -78.2% zijn.
Belangrijke informatie
38.1%
Groei van de winst
42.8%
Groei van de winst per aandeel
| Pharmaceuticals winstgroei | 23.9% |
| Inkomstengroei | 42.4% |
| Toekomstig rendement op eigen vermogen | -78.2% |
| Dekking van analisten | Good |
| Laatst bijgewerkt | 14 Nov 2024 |
Recente toekomstige groei-updates
Recent updates
US$22.20 - That's What Analysts Think Wave Life Sciences Ltd. (NASDAQ:WVE) Is Worth After These Results
Nov 15
Optimistic Investors Push Wave Life Sciences Ltd. (NASDAQ:WVE) Shares Up 95% But Growth Is Lacking
Nov 09Wave Life Sciences: Positive WVE-006 Data For AATD Leads To 2025 Catalyst
Oct 16There's Reason For Concern Over Wave Life Sciences Ltd.'s (NASDAQ:WVE) Massive 43% Price Jump
Sep 25Wave Life Sciences: Spiking On Strong DMD Data, But Not Fully De-Risked Yet
Sep 24Broker Revenue Forecasts For Wave Life Sciences Ltd. (NASDAQ:WVE) Are Surging Higher
Sep 08We're Keeping An Eye On Wave Life Sciences' (NASDAQ:WVE) Cash Burn Rate
Aug 05Pinning Down Wave Life Sciences Ltd.'s (NASDAQ:WVE) P/S Is Difficult Right Now
Jun 25We Think Wave Life Sciences (NASDAQ:WVE) Can Easily Afford To Drive Business Growth
Apr 09Wave Life Sciences' Weighty Ambition: Carving Out Obesity Niche
Mar 09Wave Life Sciences Ltd.'s (NASDAQ:WVE) 30% Price Boost Is Out Of Tune With Revenues
Mar 03We're Interested To See How Wave Life Sciences (NASDAQ:WVE) Uses Its Cash Hoard To Grow
Sep 13Wave Life Sciences Ltd. (NASDAQ:WVE) Analysts Just Cut Their EPS Forecasts Substantially
May 08Here's Why Wave Life Sciences (NASDAQ:WVE) Must Use Its Cash Wisely
Mar 30Are Investors Undervaluing Wave Life Sciences Ltd. (NASDAQ:WVE) By 47%?
Jan 20Some Analysts Just Cut Their Wave Life Sciences Ltd. (NASDAQ:WVE) Estimates
Nov 11Is Wave Life Sciences (NASDAQ:WVE) In A Good Position To Deliver On Growth Plans?
Aug 12Wave Life Sciences Q2 2022 Earnings Preview
Aug 10Will Wave Life Sciences (NASDAQ:WVE) Spend Its Cash Wisely?
Apr 21Is Wave Life Sciences (NASDAQ:WVE) In A Good Position To Invest In Growth?
Jan 11Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 12/31/2026 | 116 | -122 | -176 | -147 | 8 |
| 12/31/2025 | 69 | -153 | -153 | -138 | 10 |
| 12/31/2024 | 51 | -153 | -175 | -152 | 9 |
| 9/30/2024 | 54 | -143 | -142 | -141 | N/A |
| 6/30/2024 | 111 | -73 | -130 | -129 | N/A |
| 3/31/2024 | 113 | -62 | -139 | -138 | N/A |
| 12/31/2023 | 113 | -58 | -21 | -19 | N/A |
| 9/30/2023 | 85 | -85 | -21 | -20 | N/A |
| 6/30/2023 | 37 | -131 | -12 | -11 | N/A |
| 3/31/2023 | 15 | -151 | -4 | -2 | N/A |
| 12/31/2022 | 4 | -162 | -129 | -128 | N/A |
| 9/30/2022 | 4 | -153 | -103 | -101 | N/A |
| 6/30/2022 | 40 | -120 | -105 | -104 | N/A |
| 3/31/2022 | 43 | -118 | -85 | -84 | N/A |
| 12/31/2021 | 41 | -122 | -90 | -89 | N/A |
| 9/30/2021 | 49 | -116 | -114 | -113 | N/A |
| 6/30/2021 | 16 | -143 | -106 | -105 | N/A |
| 3/31/2021 | 16 | -145 | -135 | -134 | N/A |
| 12/31/2020 | 20 | -150 | -117 | -116 | N/A |
| 9/30/2020 | 13 | -178 | -148 | -146 | N/A |
| 6/30/2020 | 13 | -196 | -172 | -169 | N/A |
| 3/31/2020 | 17 | -197 | -168 | -164 | N/A |
| 12/31/2019 | 16 | -194 | -192 | -188 | N/A |
| 9/30/2019 | 17 | -175 | -166 | -160 | N/A |
| 6/30/2019 | 19 | -162 | -154 | -145 | N/A |
| 3/31/2019 | 16 | -156 | -50 | -41 | N/A |
| 12/31/2018 | 14 | -147 | -33 | -23 | N/A |
| 9/30/2018 | 12 | -140 | -23 | -13 | N/A |
| 6/30/2018 | 9 | -127 | N/A | -7 | N/A |
| 3/31/2018 | 5 | -116 | N/A | -99 | N/A |
| 12/31/2017 | 4 | -102 | N/A | -84 | N/A |
| 9/30/2017 | 3 | -90 | N/A | -74 | N/A |
| 6/30/2017 | 3 | -82 | N/A | -63 | N/A |
| 3/31/2017 | 2 | -69 | N/A | -42 | N/A |
| 12/31/2016 | 1 | -56 | N/A | -32 | N/A |
| 9/30/2016 | 1 | -44 | N/A | -25 | N/A |
| 6/30/2016 | 0 | -31 | N/A | -16 | N/A |
| 3/31/2016 | 0 | -24 | N/A | -18 | N/A |
| 12/31/2015 | 0 | -19 | N/A | -13 | N/A |
| 9/30/2015 | 0 | -14 | N/A | -7 | N/A |
| 6/30/2015 | 0 | -10 | N/A | -5 | N/A |
| 3/31/2015 | 0 | -8 | N/A | -5 | N/A |
| 12/31/2014 | N/A | -5 | N/A | -4 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: De verwachting is dat WVE de komende 3 jaar verliesgevend zal blijven.
Winst versus markt: De verwachting is dat WVE de komende 3 jaar verliesgevend zal blijven.
Hoge groeiwinsten: De verwachting is dat WVE de komende 3 jaar verliesgevend zal blijven.
Omzet versus markt: De omzet van WVE ( 42.4% per jaar) zal naar verwachting sneller groeien dan de markt US ( 8.9% per jaar).
Hoge groei-inkomsten: De omzet van WVE ( 42.4% per jaar) zal naar verwachting sneller groeien dan 20% per jaar.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Er wordt voorspeld dat WVE binnen 3 jaar verliesgevend zal zijn.